IMMUNITYBIO INC (IBRX) Stock Price, Quote, News and Overview

What is the stock price of IMMUNITYBIO INC today?

The current stock price of IBRX is 3.19 USD. The price decreased by -1.54% in the last trading session.

What is the ticker symbol for IMMUNITYBIO INC stock?

The exchange symbol of IMMUNITYBIO INC is IBRX and it is listed on the Nasdaq exchange.

On which exchange is IBRX stock listed?

IBRX stock is listed on the Nasdaq exchange.

What is the price forecast or stock price prediction for IMMUNITYBIO INC stock?

11 analysts have analysed IBRX and the average price target is 11.63 USD. This implies a price increase of 264.51% is expected in the next year compared to the current price of 3.19. Check the IMMUNITYBIO INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.

What is IMMUNITYBIO INC worth?

IMMUNITYBIO INC (IBRX) has a market capitalization of 2.82B USD. This makes IBRX a Mid Cap stock.

How many employees does IMMUNITYBIO INC have?

IMMUNITYBIO INC (IBRX) currently has 680 employees.

What are the support and resistance levels for IMMUNITYBIO INC (IBRX) stock?

IMMUNITYBIO INC (IBRX) has a support level at 2.91 and a resistance level at 3.2. Check the full technical report for a detailed analysis of IBRX support and resistance levels.

Is IMMUNITYBIO INC (IBRX) expected to grow?

The Revenue of IMMUNITYBIO INC (IBRX) is expected to grow by 540.5% in the next year. Check the estimates tab for more information on the IBRX EPS, Sales, EBIT and EBITDA future analyst estimates.

Should I buy IMMUNITYBIO INC (IBRX) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:

• The Technical Analysis (TA) tab contains a technical analysis of IBRX, looking at technical quality and support and resistance levels
• The Fundamental Analysis (FA) tab contains a fundamental analysis of IBRX, evaluating the profitability, health, valuation and growth aspects
• IMMUNITYBIO INC (IBRX) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
• IMMUNITYBIO INC (IBRX) Sales and EPS estimates to see what analysts future expectations are.
• IMMUNITYBIO INC (IBRX) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
• IMMUNITYBIO INC (IBRX) Insider and Institutional Ownership to learn about the owners and their transactions.
• IMMUNITYBIO INC (IBRX) Stock Chart to make your own analysis
• IMMUNITYBIO INC (IBRX) Latest news and press-releases to stay up to date.

Does IMMUNITYBIO INC (IBRX) stock pay dividends?

IBRX does not pay a dividend.

When does IMMUNITYBIO INC (IBRX) report earnings?

IMMUNITYBIO INC (IBRX) will report earnings on 2025-08-11, after the market close.

What is the Price/Earnings (PE) ratio of IMMUNITYBIO INC (IBRX)?

IMMUNITYBIO INC (IBRX) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.56).

What is the Short Interest ratio of IMMUNITYBIO INC (IBRX) stock?

The outstanding short interest for IMMUNITYBIO INC (IBRX) is 32.28% of its float. Check the ownership tab for more information on the IBRX short interest.

ChartMill assigns a fundamental rating of 3 / 10 to IBRX. Both the profitability and financial health of IBRX have multiple concerns.

Over the last trailing twelve months IBRX reported a non-GAAP Earnings per Share(EPS) of -0.56. The EPS increased by 47.17% compared to the year before.

ChartMill assigns a Buy % Consensus number of 85% to IBRX. The Buy consensus is the average rating of analysts ratings from 11 analysts.

For the next year, analysts expect an EPS growth of 18.07% and a revenue growth 540.5% for IBRX